70 related articles for article (PubMed ID: 29526679)
1. Impact of cancer diagnosis on persistence of oral antidiabetic drugs.
Létinier L; Mansiaux Y; Pariente A; Fourrier-Réglat A
Diabetes Res Clin Pract; 2018 May; 139():323-330. PubMed ID: 29526679
[TBL] [Abstract][Full Text] [Related]
2. Difficulty adhering to antidiabetic treatment: factors associated with persistence and compliance.
Guénette L; Moisan J; Breton MC; Sirois C; Grégoire JP
Diabetes Metab; 2013 May; 39(3):250-7. PubMed ID: 23523643
[TBL] [Abstract][Full Text] [Related]
3. The impact of depression medications on oral antidiabetic drug adherence in patients with diabetes and depression.
Xing S; Calip GS; Leow AD; Kim S; Schumock GT; Touchette DR; Lee TA
J Diabetes Complications; 2018 May; 32(5):492-500. PubMed ID: 29544744
[TBL] [Abstract][Full Text] [Related]
4. A retrospective database analysis of neuropathic pain and oral antidiabetic medication use and adherence among Texas adults with type 2 diabetes enrolled in Medicaid.
Oladapo AO; Barner JC; Rascati KL; Strassels SA
Clin Ther; 2012 Mar; 34(3):605-13. PubMed ID: 22386828
[TBL] [Abstract][Full Text] [Related]
5. Persistence and adherence to oral antidiabetics: a population-based cohort study.
Simard P; Presse N; Roy L; Dorais M; White-Guay B; Räkel A; Perreault S
Acta Diabetol; 2015 Jun; 52(3):547-56. PubMed ID: 25524433
[TBL] [Abstract][Full Text] [Related]
6. Adherence to oral antidiabetic medications in the pediatric population with type 2 diabetes: a retrospective database analysis.
Adeyemi AO; Rascati KL; Lawson KA; Strassels SA
Clin Ther; 2012 Mar; 34(3):712-9. PubMed ID: 22381712
[TBL] [Abstract][Full Text] [Related]
7. Effects on clinical outcomes of intensifying triple oral antidiabetic drug (OAD) therapy by initiating insulin versus enhancing OAD therapy in patients with type 2 diabetes: A nationwide population-based, propensity-score-matched cohort study.
Kuo S; Yang CT; Wu JS; Ou HT
Diabetes Obes Metab; 2019 Feb; 21(2):312-320. PubMed ID: 30187666
[TBL] [Abstract][Full Text] [Related]
8. Oral antidiabetic therapy in a large Italian sample: drug supply and compliance for different therapeutic regimens.
Vittorino Gaddi A; Benedetto D; Capello F; Di Pietro C; Cinconze E; Rossi E; De Sando V; Cevenini M; D'Alò G
Public Health; 2014 Jan; 128(1):70-6. PubMed ID: 23969148
[TBL] [Abstract][Full Text] [Related]
9. Persistence patterns with oral antidiabetes drug treatment in newly treated patients--a population-based study.
Grégoire JP; Sirois C; Blanc G; Poirier P; Moisan J
Value Health; 2010; 13(6):820-8. PubMed ID: 21054658
[TBL] [Abstract][Full Text] [Related]
10. Treatment persistence after initiating basal insulin in type 2 diabetes patients: A primary care database analysis.
Pscherer S; Chou E; Dippel FW; Rathmann W; Kostev K
Prim Care Diabetes; 2015 Oct; 9(5):377-84. PubMed ID: 25701545
[TBL] [Abstract][Full Text] [Related]
11. Association between use of oral-antidiabetic drugs and the risk of aortic aneurysm: a nested case-control analysis.
Hsu CY; Su YW; Chen YT; Tsai SH; Chang CC; Li SY; Huang PH; Chen JW; Lin SJ
Cardiovasc Diabetol; 2016 Sep; 15(1):125. PubMed ID: 27585542
[TBL] [Abstract][Full Text] [Related]
12. The Association between Depression and Medication Nonpersistence in New Users of Antidiabetic Drugs.
Lunghi C; Moisan J; Grégoire JP; Guénette L
Value Health; 2017 Jun; 20(6):728-735. PubMed ID: 28577689
[TBL] [Abstract][Full Text] [Related]
13. Persistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organization.
Cooke CE; Lee HY; Tong YP; Haines ST
Curr Med Res Opin; 2010 Jan; 26(1):231-8. PubMed ID: 19921965
[TBL] [Abstract][Full Text] [Related]
14. One-year adherence to oral antihyperglycemic medication and risk prediction of patient outcomes for adults with diabetes mellitus: An observational study.
Huber CA; Rapold R; Brüngger B; Reich O; Rosemann T
Medicine (Baltimore); 2016 Jun; 95(26):e3994. PubMed ID: 27368004
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with antidiabetic medication non-adherence in patients with incident comorbid depression.
Lunghi C; Zongo A; Moisan J; Grégoire JP; Guénette L
J Diabetes Complications; 2017 Jul; 31(7):1200-1206. PubMed ID: 28325698
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with adherence to oral antihyperglycemic monotherapy in patients with type 2 diabetes mellitus in the United Kingdom.
Tunceli K; Iglay K; Zhao C; Brodovicz KG; Radican L
Diabetes Res Clin Pract; 2015 Sep; 109(3):e27-31. PubMed ID: 26233933
[TBL] [Abstract][Full Text] [Related]
17. Persistence With Oral Antihyperglycemic Drugs in Type 2 Diabetes Mellitus Patients With Dementia in Germany.
Jacob L; Adam-Schnepf L; Kostev K
J Diabetes Sci Technol; 2018 Jan; 12(1):140-144. PubMed ID: 28681637
[TBL] [Abstract][Full Text] [Related]
18. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance.
Hertz RP; Unger AN; Lustik MB
Clin Ther; 2005 Jul; 27(7):1064-73. PubMed ID: 16154485
[TBL] [Abstract][Full Text] [Related]
19. Adherence to premixed insulin in a prefilled pen compared with a vial/syringe in people with diabetes in Singapore.
Cheen HH; Lim SH; Huang MC; Bee YM; Wee HL
Clin Ther; 2014 Jul; 36(7):1043-53. PubMed ID: 24913030
[TBL] [Abstract][Full Text] [Related]
20. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
